Cost analysis of fixed-dose combinations of proton- pump inhibitor drugs available in the Indian market
Proton-Pump Inhibitor; Fixed-Dose Combinations; Cost Analysis; Percentage Variation; Cost Ratio INTRODUCTION Modern lifestyle, food habits, and genetic factors of the Indian population along with overuse of different medications like nonsteroidal anti-inflammatory drugs can lead to increased gastric...
Gespeichert in:
| Veröffentlicht in: | National journal of physiology, pharmacy and pharmacology pharmacy and pharmacology, 2021, Vol.11 (7), p.1-1220 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1220 |
|---|---|
| container_issue | 7 |
| container_start_page | 1 |
| container_title | National journal of physiology, pharmacy and pharmacology |
| container_volume | 11 |
| creator | Bhave, Kiran Desai, Shashank Pandit, Prasad |
| description | Proton-Pump Inhibitor; Fixed-Dose Combinations; Cost Analysis; Percentage Variation; Cost Ratio INTRODUCTION Modern lifestyle, food habits, and genetic factors of the Indian population along with overuse of different medications like nonsteroidal anti-inflammatory drugs can lead to increased gastric acid secretion causing erosive gastritis, gastric esophageal reflux disease, and peptic ulcer disease. [...]the present study was conducted with the objective to evaluate the cost of FDCs of PPIs of different brands and to analyze the price variation among those available in the Indian market. Procedure * Price of FDCs of PPI in Indian rupees (INR) manufactured by different pharmaceutical companies in India, in the same strength was obtained from "Current Index of Medical Specialties" (CIMS) July-September 2020, and Indian Drug Review (IDR), August 2020, as they are a readily available source of drug information and are updated regularly * Difference in the maximum and minimum price of the same drug formulation manufactured by different pharmaceutical companies and percentage variation in prices was calculated * Percentage variation in price was calculated as follows: .. [...]in effect, the ceiling prices are influenced by the already existing prices of popular brands in |
| doi_str_mv | 10.5455/njppp.2021.11.05162202103062021 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2620982447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2620982447</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1467-a81635679fbb9e22b4e64d445f16e222db5e896ce1cec6c31c2aac03e76ab1603</originalsourceid><addsrcrecordid>eNplkM1OwzAQhC0EElXpO1jiwCnBaztOc0Ko4qdSJS5wtmzHaV1SO8QJom-P03JjL7OrHa1mP4TugOQFL4p7v--6LqeEQg6QkwIEnQbCiJj0As0oZZAxSsRl6pNmXJT0Gi1i3JNUFYfkmKHtKsQBK6_aY3QRhwY37sfWWR2ixSYctPNqcMGfVl0fhuAz3I2HDju_c9oNocd1P24jVt_KtUq3Nm3wsLN47WunPD6o_tMON-iqUW20iz-do4_np_fVa7Z5e1mvHjeZgRQwU0sQrBBl1WhdWUo1t4LXnBcNiDTSWhd2WQljwVgjDANDlTKE2VIoDYKwObo9301Zv0YbB7kPY5_ei5ImNNWScl4m18PZZfoQY28b2fUuBT1KIHICLE-A5cRSAsh_gNkvCnhxFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2620982447</pqid></control><display><type>article</type><title>Cost analysis of fixed-dose combinations of proton- pump inhibitor drugs available in the Indian market</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Bhave, Kiran ; Desai, Shashank ; Pandit, Prasad</creator><creatorcontrib>Bhave, Kiran ; Desai, Shashank ; Pandit, Prasad</creatorcontrib><description>Proton-Pump Inhibitor; Fixed-Dose Combinations; Cost Analysis; Percentage Variation; Cost Ratio INTRODUCTION Modern lifestyle, food habits, and genetic factors of the Indian population along with overuse of different medications like nonsteroidal anti-inflammatory drugs can lead to increased gastric acid secretion causing erosive gastritis, gastric esophageal reflux disease, and peptic ulcer disease. [...]the present study was conducted with the objective to evaluate the cost of FDCs of PPIs of different brands and to analyze the price variation among those available in the Indian market. Procedure * Price of FDCs of PPI in Indian rupees (INR) manufactured by different pharmaceutical companies in India, in the same strength was obtained from "Current Index of Medical Specialties" (CIMS) July-September 2020, and Indian Drug Review (IDR), August 2020, as they are a readily available source of drug information and are updated regularly * Difference in the maximum and minimum price of the same drug formulation manufactured by different pharmaceutical companies and percentage variation in prices was calculated * Percentage variation in price was calculated as follows: .. [...]in effect, the ceiling prices are influenced by the already existing prices of popular brands in</description><identifier>ISSN: 2320-4672</identifier><identifier>EISSN: 2231-3206</identifier><identifier>DOI: 10.5455/njppp.2021.11.05162202103062021</identifier><language>eng</language><publisher>Surat: Association of Physiologists, Pharmacists & Pharmacologists</publisher><subject>Acids ; Brand names ; Cost analysis ; Drug dosages ; Expenditures ; Generic drugs ; Patients ; Pharmaceutical industry ; Prescription drugs ; Prices ; Pricing policies</subject><ispartof>National journal of physiology, pharmacy and pharmacology, 2021, Vol.11 (7), p.1-1220</ispartof><rights>2021. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1467-a81635679fbb9e22b4e64d445f16e222db5e896ce1cec6c31c2aac03e76ab1603</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids></links><search><creatorcontrib>Bhave, Kiran</creatorcontrib><creatorcontrib>Desai, Shashank</creatorcontrib><creatorcontrib>Pandit, Prasad</creatorcontrib><title>Cost analysis of fixed-dose combinations of proton- pump inhibitor drugs available in the Indian market</title><title>National journal of physiology, pharmacy and pharmacology</title><description>Proton-Pump Inhibitor; Fixed-Dose Combinations; Cost Analysis; Percentage Variation; Cost Ratio INTRODUCTION Modern lifestyle, food habits, and genetic factors of the Indian population along with overuse of different medications like nonsteroidal anti-inflammatory drugs can lead to increased gastric acid secretion causing erosive gastritis, gastric esophageal reflux disease, and peptic ulcer disease. [...]the present study was conducted with the objective to evaluate the cost of FDCs of PPIs of different brands and to analyze the price variation among those available in the Indian market. Procedure * Price of FDCs of PPI in Indian rupees (INR) manufactured by different pharmaceutical companies in India, in the same strength was obtained from "Current Index of Medical Specialties" (CIMS) July-September 2020, and Indian Drug Review (IDR), August 2020, as they are a readily available source of drug information and are updated regularly * Difference in the maximum and minimum price of the same drug formulation manufactured by different pharmaceutical companies and percentage variation in prices was calculated * Percentage variation in price was calculated as follows: .. [...]in effect, the ceiling prices are influenced by the already existing prices of popular brands in</description><subject>Acids</subject><subject>Brand names</subject><subject>Cost analysis</subject><subject>Drug dosages</subject><subject>Expenditures</subject><subject>Generic drugs</subject><subject>Patients</subject><subject>Pharmaceutical industry</subject><subject>Prescription drugs</subject><subject>Prices</subject><subject>Pricing policies</subject><issn>2320-4672</issn><issn>2231-3206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNplkM1OwzAQhC0EElXpO1jiwCnBaztOc0Ko4qdSJS5wtmzHaV1SO8QJom-P03JjL7OrHa1mP4TugOQFL4p7v--6LqeEQg6QkwIEnQbCiJj0As0oZZAxSsRl6pNmXJT0Gi1i3JNUFYfkmKHtKsQBK6_aY3QRhwY37sfWWR2ixSYctPNqcMGfVl0fhuAz3I2HDju_c9oNocd1P24jVt_KtUq3Nm3wsLN47WunPD6o_tMON-iqUW20iz-do4_np_fVa7Z5e1mvHjeZgRQwU0sQrBBl1WhdWUo1t4LXnBcNiDTSWhd2WQljwVgjDANDlTKE2VIoDYKwObo9301Zv0YbB7kPY5_ei5ImNNWScl4m18PZZfoQY28b2fUuBT1KIHICLE-A5cRSAsh_gNkvCnhxFA</recordid><startdate>2021</startdate><enddate>2021</enddate><creator>Bhave, Kiran</creator><creator>Desai, Shashank</creator><creator>Pandit, Prasad</creator><general>Association of Physiologists, Pharmacists & Pharmacologists</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>2021</creationdate><title>Cost analysis of fixed-dose combinations of proton- pump inhibitor drugs available in the Indian market</title><author>Bhave, Kiran ; Desai, Shashank ; Pandit, Prasad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1467-a81635679fbb9e22b4e64d445f16e222db5e896ce1cec6c31c2aac03e76ab1603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acids</topic><topic>Brand names</topic><topic>Cost analysis</topic><topic>Drug dosages</topic><topic>Expenditures</topic><topic>Generic drugs</topic><topic>Patients</topic><topic>Pharmaceutical industry</topic><topic>Prescription drugs</topic><topic>Prices</topic><topic>Pricing policies</topic><toplevel>online_resources</toplevel><creatorcontrib>Bhave, Kiran</creatorcontrib><creatorcontrib>Desai, Shashank</creatorcontrib><creatorcontrib>Pandit, Prasad</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science & Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>National journal of physiology, pharmacy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhave, Kiran</au><au>Desai, Shashank</au><au>Pandit, Prasad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost analysis of fixed-dose combinations of proton- pump inhibitor drugs available in the Indian market</atitle><jtitle>National journal of physiology, pharmacy and pharmacology</jtitle><date>2021</date><risdate>2021</risdate><volume>11</volume><issue>7</issue><spage>1</spage><epage>1220</epage><pages>1-1220</pages><issn>2320-4672</issn><eissn>2231-3206</eissn><abstract>Proton-Pump Inhibitor; Fixed-Dose Combinations; Cost Analysis; Percentage Variation; Cost Ratio INTRODUCTION Modern lifestyle, food habits, and genetic factors of the Indian population along with overuse of different medications like nonsteroidal anti-inflammatory drugs can lead to increased gastric acid secretion causing erosive gastritis, gastric esophageal reflux disease, and peptic ulcer disease. [...]the present study was conducted with the objective to evaluate the cost of FDCs of PPIs of different brands and to analyze the price variation among those available in the Indian market. Procedure * Price of FDCs of PPI in Indian rupees (INR) manufactured by different pharmaceutical companies in India, in the same strength was obtained from "Current Index of Medical Specialties" (CIMS) July-September 2020, and Indian Drug Review (IDR), August 2020, as they are a readily available source of drug information and are updated regularly * Difference in the maximum and minimum price of the same drug formulation manufactured by different pharmaceutical companies and percentage variation in prices was calculated * Percentage variation in price was calculated as follows: .. [...]in effect, the ceiling prices are influenced by the already existing prices of popular brands in</abstract><cop>Surat</cop><pub>Association of Physiologists, Pharmacists & Pharmacologists</pub><doi>10.5455/njppp.2021.11.05162202103062021</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2320-4672 |
| ispartof | National journal of physiology, pharmacy and pharmacology, 2021, Vol.11 (7), p.1-1220 |
| issn | 2320-4672 2231-3206 |
| language | eng |
| recordid | cdi_proquest_journals_2620982447 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Acids Brand names Cost analysis Drug dosages Expenditures Generic drugs Patients Pharmaceutical industry Prescription drugs Prices Pricing policies |
| title | Cost analysis of fixed-dose combinations of proton- pump inhibitor drugs available in the Indian market |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T06%3A49%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost%20analysis%20of%20fixed-dose%20combinations%20of%20proton-%20pump%20inhibitor%20drugs%20available%20in%20the%20Indian%20market&rft.jtitle=National%20journal%20of%20physiology,%20pharmacy%20and%20pharmacology&rft.au=Bhave,%20Kiran&rft.date=2021&rft.volume=11&rft.issue=7&rft.spage=1&rft.epage=1220&rft.pages=1-1220&rft.issn=2320-4672&rft.eissn=2231-3206&rft_id=info:doi/10.5455/njppp.2021.11.05162202103062021&rft_dat=%3Cproquest_cross%3E2620982447%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2620982447&rft_id=info:pmid/&rfr_iscdi=true |